Rapaflo Oral Capsule 4Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Rapaflo: Oral capsule (4mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_16638.JPG
Rapaflo 4mg Cap
Actavis Inc. formerly WatsonPharma Inc
Pill Identification: WATSON 151 4mg 

What is this Medicine?

SILODOSIN (SYE lo DOE sin) is used to treat enlargement of the prostate gland in men, a condition called benign prostatic hyperplasia or BPH. It is not for use in women.

CVS Pharmacy Patient Statistics for Rapaflo: Oral capsule(4mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

Rapaflo 4mg Capsule

NDC: 525440151
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Benign Prostatic Hyperplasia (BPH)

Storage Information
Protect from light
Protect from moisture
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Rapaflo 4mg Capsule
Drug Image file DrugItem_16638.JPG
Actavis Inc. formerly WatsonPharma Inc
Pill Identification: WATSON 151 4mg 
Shape: capsule
Color: white

Reported Side Effects for Rapaflo 4mg Capsule

Sinus Infection Incidence:
1.0-2.0%*
Severity: MILD
Onset: DELAYED
Runny Nose Incidence:
1.0-2.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
1.0-2.0%*
Severity: MILD
Onset: EARLY
Weakness Incidence:
1.0-2.0%*
Severity: MILD
Onset: DELAYED
Inability To Sleep Incidence:
1.0-2.0%*
Severity: MILD
Onset: EARLY
Stuffy Nose Incidence:
2.1%*
Severity: MILD
Onset: EARLY
Sore Throat Incidence:
2.4%*
Severity: MILD
Onset: DELAYED
Headache Incidence:
2.4%*
Severity: MILD
Onset: EARLY
Postural Low Blood Pressure Incidence:
2.6%*
Severity: MODERATE
Onset: DELAYED
Loose Stools Incidence:
2.6%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
3.2%*
Severity: MILD
Onset: EARLY
Uncontrolled Urination Incidence:
6.3%*
Severity: MODERATE
Onset: EARLY
Excessive Thirst Incidence:
10.3%*
Severity: MILD
Onset: EARLY
Ejaculation Dysfunction Incidence:
22.3-28.1%*
Severity: MODERATE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Rapaflo 4mg Capsule

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Moderate Lifestyle Interaction
Grapefruit juice and Rapaflo 4mg Capsule(Silodosin)
Grapefruit juice and Silodosin(Silodosin)
Grapefruit juice may increase the actions of Silodosin and potentially increase its side effects. If your blood pressure drops too low while taking Silodosin, you may become dizzy or feel faint. To limit this interaction, do not stand or sit up too quickly. You should also limit or avoid grapefruit juice while taking Silodosin. Contact your prescriber if you have dizziness or other side effects that do not go away.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Rapaflo

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5